These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8037138)

  • 1. Efficacy of class Ia antiarrhythmic drugs in converting atrial fibrillation unassociated with organic heart disease and their relation to atrial electrophysiologic characteristics.
    Fujiki A; Yoshida S; Tani M; Inoue H
    Am J Cardiol; 1994 Aug; 74(3):282-3. PubMed ID: 8037138
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.
    Bauernfeind RA; Swiryn SP; Strasberg B; Palileo E; Scagliotti D; Rosen KM
    Am Heart J; 1982 Jun; 103(6):941-9. PubMed ID: 7081034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias.
    Hiejima K; Suzuki F; Takahashi M; Satake S
    Jpn Circ J; 1983 Jan; 47(1):98-104. PubMed ID: 6827776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of invasive and non-invasive electrophysiologic studies in the selection of antiarrhythmic drugs for the patients with paroxysmal supraventricular tachyarrhythmia.
    Satake S; Hiejima K; Moroi Y; Hirao K; Kubo I; Suzuki F; Suzuki F
    Jpn Circ J; 1985 Mar; 49(3):345-50. PubMed ID: 3981793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of class IA antiarrhythmic drugs on the reentrant circuit in common human atrial flutter.
    Ohga N; Inoue T; Doi T; Yoshida A; Yokoyama M
    Jpn Circ J; 1995 Dec; 59(12):799-807. PubMed ID: 8788371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of disopyramide on initiation of atrial fibrillation and relation to effective refractory period.
    Ito M; Onodera S; Hashimoto J; Noshiro H; Shinoda S; Nagashima M; Suzuki H
    Am J Cardiol; 1989 Mar; 63(9):561-6. PubMed ID: 2919560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of class IA antiarrhythmic drug on the common type of atrial flutter in combination with pacing therapy.
    Fujimoto T; Inoue T; Ogawa H; Miwa S; Ohnishi Y; Yoneda N; Kaneda S; Itoh S; Fukuzaki H
    Jpn Circ J; 1989 Mar; 53(3):237-44. PubMed ID: 2746840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wavelength index: a predictor of the response to disopyramide in paroxysmal lone atrial fibrillation.
    Kumagai K; Gondo N; Matsuo K; Annoura M; Moroe K; Nakashima Y; Hiroki T; Arakawa K
    Cardiology; 1994; 85(3-4):184-92. PubMed ID: 7987874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size.
    Halpern SW; Ellrodt G; Singh BN; Mandel WJ
    Br Heart J; 1980 Nov; 44(5):589-95. PubMed ID: 7437202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of heart rate variability in a patient with paroxysmal atrial fibrillation.
    van den Berg MP; Haaksma J; Brouwer J; Crijns HJ; Lie KI
    Eur Heart J; 1995 Dec; 16(12):2011-2. PubMed ID: 8682048
    [No Abstract]   [Full Text] [Related]  

  • 12. Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation.
    Kubara I; Ikeda H; Hiraki T; Yoshida T; Ohga M; Imaizumi T
    J Cardiovasc Electrophysiol; 1999 May; 10(5):670-9. PubMed ID: 10355923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous anterograde fast-slow atrioventricular nodal pathway conduction after procainamide.
    Gomes JA; Kang PS; Kelen G; Khan R; El-Sherif N
    Am J Cardiol; 1980 Oct; 46(4):677-84. PubMed ID: 7416027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of supraventricular arrhythmias.
    Donaldson RM
    Br J Hosp Med; 1979 Apr; 21(4):344, 348, 353-4. PubMed ID: 35261
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of drug efficacy for preventing paroxysmal atrial fibrillation].
    Fujiki A; Yoshida S; Tani M; Sasayama S
    Jpn Circ J; 1992; 56 Suppl 5():1454-7. PubMed ID: 1291741
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of intravenous disopyramide on induction and termination of paroxysmal supraventricular tachycardia via an accessory pathway].
    Komatsu C; Ishinaga T; Tateishi O; Tokuhisa Y; Hara M; Sanada T; Kanae K; Satoh Y; Yoshimura S
    Kokyu To Junkan; 1984 Apr; 32(4):409-14. PubMed ID: 6463419
    [No Abstract]   [Full Text] [Related]  

  • 17. [Electrophysiological action of disopyramide].
    Grosu AA; Malakhov VI; Smetnev AS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):51-5. PubMed ID: 7138657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic characteristics of human atrial muscle in paroxysmal atrial fibrillation.
    Hashiba K; Centurion OA; Shimizu A
    Am Heart J; 1996 Apr; 131(4):778-89. PubMed ID: 8721655
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias.
    Camm J; Ward D; Spurrell RA
    Br J Clin Pharmacol; 1979 Nov; 8(5):441-9. PubMed ID: 508548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biatrial pacing--new possibility in the non-pharmacologic treatment of drug-resistant paroxysmal atrial fibrillation].
    Merkely B; Vágó H; Gellér L; Zima E; Tomcsányi J; Bodor E
    Orv Hetil; 2001 Feb; 142(5):235-40. PubMed ID: 11243011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.